Jane Street Group, LLC Adaptimmune Therapeutics PLC Transaction History

Jane Street Group, LLC

  • $616 Billion
  • Q3 2025

A detailed history of Jane Street Group, LLC transactions in Adaptimmune Therapeutics PLC stock. As of the latest transaction made, Jane Street Group, LLC holds 2,805,345 shares of ADAP stock, worth $84,160. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,805,345
Holding current value
$84,160
% of portfolio
0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
BUY
$0.04 - $0.35 $112,213 - $981,870
2,805,345 New
2,805,345 $392,000
Q4 2024

Feb 14, 2025
BUY
$0.54 - $0.95 $82,501 - $145,141
152,780 Added 87.73%
326,937 $176,000
Q3 2024

Nov 14, 2024
BUY
$0.92 - $1.39 $90,694 - $137,027
98,581 Added 130.44%
174,157 $165,000
Q2 2024

Aug 14, 2024
BUY
$0.83 - $1.47 $62,728 - $111,096
75,576 New
75,576 $74,000
Q4 2023

Feb 14, 2024
BUY
$0.43 - $0.79 $41,959 - $77,088
97,580 New
97,580 $77,000
Q2 2022

Aug 16, 2022
BUY
$1.33 - $2.28 $58,634 - $100,516
44,086 New
44,086 $75,000
Q1 2022

May 17, 2022
SELL
$1.73 - $4.06 $35,030 - $82,210
-20,249 Closed
0 $0
Q4 2021

Feb 15, 2022
SELL
$3.5 - $5.68 $75,883 - $123,148
-21,681 Reduced 51.71%
20,249 $76,000
Q3 2021

Nov 16, 2021
BUY
$3.44 - $6.37 $38,644 - $71,560
11,234 Added 36.6%
41,930 $216,000
Q2 2021

Aug 16, 2021
BUY
$3.86 - $5.78 $47,790 - $71,562
12,381 Added 67.6%
30,696 $130,000
Q1 2021

May 18, 2021
SELL
$4.9 - $6.83 $49,284 - $68,696
-10,058 Reduced 35.45%
18,315 $97,000
Q4 2020

Feb 17, 2021
BUY
$4.0 - $9.2 $113,492 - $261,031
28,373 New
28,373 $153,000
Q2 2018

Aug 15, 2018
SELL
$10.42 - $13.74 $155,747 - $205,371
-14,947 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$7.1 - $11.56 $106,123 - $172,787
14,947 New
14,947 $168,000

Others Institutions Holding ADAP

# of Institutions
65
Shares Held
91.3M
Call Options Held
907
Put Options Held
0
View Full List

About Adaptimmune Therapeutics PLC

ADAP Quotes by TradingView
  • Ticker ADAP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 163,370,000
  • Market Cap $4.9M
  • Description
  • Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...
More about ADAP
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email